Literature DB >> 11756328

A key role for beta-cell cytosolic phospholipase A(2) in the maintenance of insulin stores but not in the initiation of insulin secretion.

Shanta J Persaud1, Helen M Roderigo-Milne, Paul E Squires, David Sugden, Caroline P D Wheeler-Jones, Phil J Marsh, Véronique D Belin, Melanie J Luther, Peter M Jones.   

Abstract

Cytosolic phospholipase A(2) (cPLA(2)) is a Ca(2+)-sensitive enzyme that has been implicated in insulin secretion in response to agents that elevate beta-cell intracellular Ca(2+) ([Ca(2+)](i)). We generated clones of the MIN6 beta-cell line that stably underexpress cPLA(2) by transfection with a vector in which cPLA(2) cDNA had been inserted in the antisense orientation. Reduced expression of cPLA(2) was confirmed by Western blotting. The insulin content of cPLA(2)-deficient MIN6 cells was reduced by approximately 90%, but they showed no decrease in preproinsulin mRNA expression. Measurements of stimulus-dependent changes in [Ca(2+)](i) indicated that reduced expression of cPLA(2) did not affect the capacity of MIN6 cells to show elevations in Ca(2+) in response to depolarizing stimuli. Perifusion experiments indicated that cPLA(2) underexpressing MIN6 pseudoislets responded to glucose, tolbutamide, and KCl with insulin secretory profiles similar to those of cPLA(2) expressing pseudoislets, but that secretion was not maintained with continued stimulus. Analysis of the ultrastructure of cPLA(2)-deficient MIN6 cells by electron microscopy revealed that they contained very few mature insulin secretory granules, but there was an abundance of non-electron-dense vesicles. These data are consistent with a role for cPLA(2) in the maintenance of insulin stores, but they suggest that it is not required for the initiation of insulin secretion from beta-cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756328     DOI: 10.2337/diabetes.51.1.98

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

1.  Islet alpha-cells do not influence insulin secretion from beta-cells through cell-cell contact.

Authors:  Helen Brereton; Melanie J Carvell; Shanta J Persaud; Peter M Jones
Journal:  Endocrine       Date:  2007-02       Impact factor: 3.633

2.  Inhibition of Ca2+-independent phospholipase A2 results in insufficient insulin secretion and impaired glucose tolerance.

Authors:  Keying Song; Xu Zhang; Chunying Zhao; Natasha T Ang; Zhongmin Alex Ma
Journal:  Mol Endocrinol       Date:  2004-10-07

3.  Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice.

Authors:  J Cantley; A I Choudhury; H Asare-Anane; C Selman; S Lingard; H Heffron; P Herrera; S J Persaud; D J Withers
Journal:  Diabetologia       Date:  2007-03-29       Impact factor: 10.122

4.  Kisspeptin stimulation of insulin secretion: mechanisms of action in mouse islets and rats.

Authors:  J E Bowe; A J King; J S Kinsey-Jones; V L Foot; X F Li; K T O'Byrne; S J Persaud; P M Jones
Journal:  Diabetologia       Date:  2009-02-17       Impact factor: 10.122

5.  Deletion of the von Hippel-Lindau gene in pancreatic beta cells impairs glucose homeostasis in mice.

Authors:  James Cantley; Colin Selman; Deepa Shukla; Andrey Y Abramov; Frauke Forstreuter; Miguel A Esteban; Marc Claret; Steven J Lingard; Melanie Clements; Sarah K Harten; Henry Asare-Anane; Rachel L Batterham; Pedro L Herrera; Shanta J Persaud; Michael R Duchen; Patrick H Maxwell; Dominic J Withers
Journal:  J Clin Invest       Date:  2008-12-08       Impact factor: 14.808

6.  Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans.

Authors:  R D Ramracheya; D S Muller; Y Wu; B J Whitehouse; G C Huang; S A Amiel; J Karalliedde; G Viberti; P M Jones; S J Persaud
Journal:  Diabetologia       Date:  2006-01-17       Impact factor: 10.122

7.  In vitro expression of NGN3 identifies RAB3B as the predominant Ras-associated GTP-binding protein 3 family member in human islets.

Authors:  Karen Piper Hanley; Tom Hearn; Andrew Berry; Melanie J Carvell; Ann-Marie Patch; Louise J Williams; Sarah A Sugden; David I Wilson; Sian Ellard; Neil A Hanley
Journal:  J Endocrinol       Date:  2010-08-31       Impact factor: 4.286

8.  Cytosolic and Calcium-Independent Phospholipases A2 Activation and Prostaglandins E2 Are Associated with Escherichia coli-Induced Reduction of Insulin Secretion in INS-1E Cells.

Authors:  Nunzia Caporarello; Mario Salmeri; Marina Scalia; Carla Motta; Cristina Parrino; Lucia Frittitta; Melania Olivieri; Martina Cristaldi; Roberto Avola; Vincenzo Bramanti; Maria Antonietta Toscano; Carmelina Daniela Anfuso; Gabriella Lupo
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

9.  Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug.

Authors:  Lisa Sanderson; Marcelo da Silva; Gayathri N Sekhar; Rachel C Brown; Hollie Burrell-Saward; Mehmet Fidanboylu; Bo Liu; Lea Ann Dailey; Cécile A Dreiss; Chris Lorenz; Mark Christie; Shanta J Persaud; Vanessa Yardley; Simon L Croft; Margarita Valero; Sarah A Thomas
Journal:  PLoS Negl Trop Dis       Date:  2021-04-15

10.  The novel chemokine receptor, G-protein-coupled receptor 75, is expressed by islets and is coupled to stimulation of insulin secretion and improved glucose homeostasis.

Authors:  Bo Liu; Zoheb Hassan; Stefan Amisten; Aileen J King; James E Bowe; Guo Cai Huang; Peter M Jones; Shanta J Persaud
Journal:  Diabetologia       Date:  2013-08-27       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.